Discontinuation report SPORANOX
| Report ID | 272439 |
| Drug Identification Number | 02047454 |
| Brand name | SPORANOX |
| Common or Proper name | SPORANOX* 100MG 30'S |
| Company Name | JANSSEN INC |
| Market Status | MARKETED |
| Active Ingredient(s) | ITRACONAZOLE |
| Strength(s) | 100MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL ORAL |
| Packaging size | 30 capsules |
| ATC code | J02AC |
| ATC description | ANTIMYCOTICS FOR SYSTEMIC USE |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2026-03-31 |
| Actual discontinuation date | |
| Remaining supply date | 2026-03-31 |
| Discontinuation status | To be discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | Sufficient inventory to support sales until discontinuation date |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 19 GREEN BELT DRIVE TORONTO, ONTARIO CANADA M3C 1L9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2025-11-24 | French | Compare |
| v1 | 2025-11-24 | English | Compare |
Showing 1 to 2 of 2